Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

about

Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia.

Item

http://www.wikidata.org/entity/Q42363520

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Catalase activity of IgG antib ...... d patients with schizophrenia.

@en

Catalase activity of IgG antib ...... d patients with schizophrenia.

@nl

type

Item

label

Catalase activity of IgG antib ...... d patients with schizophrenia.

@en

Catalase activity of IgG antib ...... d patients with schizophrenia.

@nl

prefLabel

Catalase activity of IgG antib ...... d patients with schizophrenia.

@en

Catalase activity of IgG antib ...... d patients with schizophrenia.

@nl

P1476

Catalase activity of IgG antib ...... nd patients with schizophrenia

@en

P2093

Arkadiy V Semke

http://www.w3.org/2001/XMLSchema#string

Georgy A Nevinsky

http://www.w3.org/2001/XMLSchema#string

Ludmila P Smirnova

http://www.w3.org/2001/XMLSchema#string

Nikolay A Bokhan

http://www.w3.org/2001/XMLSchema#string

Svetlana A Ivanova

http://www.w3.org/2001/XMLSchema#string

P2860

The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein

Antioxidant enzymes and human diseases

Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited

Structure/Function Relationships of [NiFe]- and [FeFe]-Hydrogenases

Cortical inhibitory neurons and schizophrenia

Catalase in vitro

The free radical theory of aging matures

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Systemic lupus erythematosus: molecular cloning of several recombinant DNase monoclonal kappa light chains with different catalytic properties.

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.

P304

e0183867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183867

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28945759

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5612456

http://www.w3.org/2001/XMLSchema#string